middle.news
How Resmed’s 9% Revenue Growth Signals a New Era in Home Healthcare
8:35am on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
How Resmed’s 9% Revenue Growth Signals a New Era in Home Healthcare
8:35am on Friday 31st of October, 2025 AEDT
Key Points
9% revenue increase to $1.3 billion, 8% on constant currency basis
Gross margin expanded by 290 basis points to 61.5%
Non-GAAP diluted EPS rose 16% to $2.55
Operating cash flow reached $457 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE